title: Influence of hepatitis C virus coinfection on lipid abnormalities in HIV-positive patients after highly active antiretroviral therapy.
authors.forename: Carlo
authors.initials: C
authors.lastname: Torti
authors.forename: Andrea
authors.initials: A
authors.lastname: Patroni
authors.forename: Carmine
authors.initials: C
authors.lastname: Tinelli
authors.forename: Intissar
authors.initials: I
authors.lastname: Sleiman
authors.forename: Eugenia
authors.initials: E
authors.lastname: Quiros-Roldan
authors.forename: Massimo
authors.initials: M
authors.lastname: Puoti
authors.forename: Francesco
authors.initials: F
authors.lastname: Castelli
mesh_terms: D000328:Adult; D023241:Antiretroviral Therapy, Highly Active; D002784:Cholesterol / Q000097:blood*; D005260:Female; D015658:HIV Infections / Q000150:complications*; D015497:HIV-1 / Q000302:isolation & purification; D016174:Hepacivirus / Q000302:isolation & purification; D006526:Hepatitis C / Q000150:complications*; D018937:Hepatitis C Antibodies / Q000097:blood; D006801:Humans; D008297:Male; D014280:Triglycerides / Q000097:blood*
chemical_list: D018937:Hepatitis C Antibodies; D014280:Triglycerides; D002784:Cholesterol